Lead acetate-induced contraction in rabbit mesenteric artery

Interaction with calcium and protein kinase C

Stephanie W. Watts, Siangshu Chai, R Clinton Webb

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Animal studies have demonstrated that low-level lead exposure produces hypertension and that lead can cause contraction of vascular smooth muscle directly. The physiological effects of lead have been associated with both stimulation and inhibition of protein kinase C (PKC). Given that vascular smooth muscle contractility is generally enhanced when protein kinase C is activated, we have tested the hypothesis that lead contracts vascular smooth muscle via stimulation of PKC. Helically-cut strips of rabbit mesenteric artery were mounted in muscle baths for measurement of isometric force development. Cumulative addition of lead acetate (10-10-10-3 M) to the muscle bath produced contractions (concentration necessary to produce half-maximal response -log EC50 = 5.16 ± 0.07). Maximal contraction to lead acetate in arteries denuded of endothelium did not differ from those in intact vessels, supporting the hypothesis that lead-induced contraction is an endothelium-independent event. Contractions to lead acetate were potentiated by the PKC activators, phorbol 12-myristate 13-acetate (TPA; 3 × 10-7 M) and mezerein (3 × 10-7 M), as indicated by leftward shifts in the concentration-response curve and increase in the potency of lead (-log EC50 with TPA: 6.94 ± 0.07; -log EC50 with mezerein: 6.07 ± 0.04). H-7 (6 × 10-6 M), an inhibitor of PKC, decreased maximal contraction to lead ~65% and slightly, but insignificantly, decreased the potency of lead (-log EC50 = 4.82 ± 0.1). The inactive phorbol ester, phorbol 12-myristate 13-acetate 4-0-methyl ether (1 × 10-6 M), did not alter contractile responses to lead (-log EC50 = 4.92 ± 0.09). Vascular contraction to lead partially depends on extracellular calcium as the L-type voltage-gated calcium channel antagonist, verapamil (3 × 10-6 M), decreased leadinduced contractions by 50%. These data indicate that lead interacts with PKC in an endothelium-independent, calcium-dependent manner to cause vascular smooth muscle contraction and suggest that lead-induced increases in vascular contractility may play a role in lead-induced hypertension.

Original languageEnglish (US)
Pages (from-to)55-65
Number of pages11
JournalToxicology
Volume99
Issue number1-2
DOIs
StatePublished - May 5 1995
Externally publishedYes

Fingerprint

Mesenteric Arteries
Protein Kinase C
Rabbits
Calcium
Muscle
Vascular Smooth Muscle
Endothelium
Baths
Blood Vessels
Acetates
Hypertension
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Lead
lead acetate
Methyl Ethers
Muscles
Calcium Channel Blockers
Phorbol Esters
Contracts
Muscle Contraction

Keywords

  • Calcium
  • Endothelium
  • Environmental lead
  • Phorbol esters
  • Protein kinase C
  • Vascular smooth muscle

ASJC Scopus subject areas

  • Toxicology

Cite this

Lead acetate-induced contraction in rabbit mesenteric artery : Interaction with calcium and protein kinase C. / Watts, Stephanie W.; Chai, Siangshu; Webb, R Clinton.

In: Toxicology, Vol. 99, No. 1-2, 05.05.1995, p. 55-65.

Research output: Contribution to journalArticle

@article{0d907ae74dd746ba892df82e3eba1368,
title = "Lead acetate-induced contraction in rabbit mesenteric artery: Interaction with calcium and protein kinase C",
abstract = "Animal studies have demonstrated that low-level lead exposure produces hypertension and that lead can cause contraction of vascular smooth muscle directly. The physiological effects of lead have been associated with both stimulation and inhibition of protein kinase C (PKC). Given that vascular smooth muscle contractility is generally enhanced when protein kinase C is activated, we have tested the hypothesis that lead contracts vascular smooth muscle via stimulation of PKC. Helically-cut strips of rabbit mesenteric artery were mounted in muscle baths for measurement of isometric force development. Cumulative addition of lead acetate (10-10-10-3 M) to the muscle bath produced contractions (concentration necessary to produce half-maximal response -log EC50 = 5.16 ± 0.07). Maximal contraction to lead acetate in arteries denuded of endothelium did not differ from those in intact vessels, supporting the hypothesis that lead-induced contraction is an endothelium-independent event. Contractions to lead acetate were potentiated by the PKC activators, phorbol 12-myristate 13-acetate (TPA; 3 × 10-7 M) and mezerein (3 × 10-7 M), as indicated by leftward shifts in the concentration-response curve and increase in the potency of lead (-log EC50 with TPA: 6.94 ± 0.07; -log EC50 with mezerein: 6.07 ± 0.04). H-7 (6 × 10-6 M), an inhibitor of PKC, decreased maximal contraction to lead ~65{\%} and slightly, but insignificantly, decreased the potency of lead (-log EC50 = 4.82 ± 0.1). The inactive phorbol ester, phorbol 12-myristate 13-acetate 4-0-methyl ether (1 × 10-6 M), did not alter contractile responses to lead (-log EC50 = 4.92 ± 0.09). Vascular contraction to lead partially depends on extracellular calcium as the L-type voltage-gated calcium channel antagonist, verapamil (3 × 10-6 M), decreased leadinduced contractions by 50{\%}. These data indicate that lead interacts with PKC in an endothelium-independent, calcium-dependent manner to cause vascular smooth muscle contraction and suggest that lead-induced increases in vascular contractility may play a role in lead-induced hypertension.",
keywords = "Calcium, Endothelium, Environmental lead, Phorbol esters, Protein kinase C, Vascular smooth muscle",
author = "Watts, {Stephanie W.} and Siangshu Chai and Webb, {R Clinton}",
year = "1995",
month = "5",
day = "5",
doi = "10.1016/0300-483X(94)03003-K",
language = "English (US)",
volume = "99",
pages = "55--65",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Lead acetate-induced contraction in rabbit mesenteric artery

T2 - Interaction with calcium and protein kinase C

AU - Watts, Stephanie W.

AU - Chai, Siangshu

AU - Webb, R Clinton

PY - 1995/5/5

Y1 - 1995/5/5

N2 - Animal studies have demonstrated that low-level lead exposure produces hypertension and that lead can cause contraction of vascular smooth muscle directly. The physiological effects of lead have been associated with both stimulation and inhibition of protein kinase C (PKC). Given that vascular smooth muscle contractility is generally enhanced when protein kinase C is activated, we have tested the hypothesis that lead contracts vascular smooth muscle via stimulation of PKC. Helically-cut strips of rabbit mesenteric artery were mounted in muscle baths for measurement of isometric force development. Cumulative addition of lead acetate (10-10-10-3 M) to the muscle bath produced contractions (concentration necessary to produce half-maximal response -log EC50 = 5.16 ± 0.07). Maximal contraction to lead acetate in arteries denuded of endothelium did not differ from those in intact vessels, supporting the hypothesis that lead-induced contraction is an endothelium-independent event. Contractions to lead acetate were potentiated by the PKC activators, phorbol 12-myristate 13-acetate (TPA; 3 × 10-7 M) and mezerein (3 × 10-7 M), as indicated by leftward shifts in the concentration-response curve and increase in the potency of lead (-log EC50 with TPA: 6.94 ± 0.07; -log EC50 with mezerein: 6.07 ± 0.04). H-7 (6 × 10-6 M), an inhibitor of PKC, decreased maximal contraction to lead ~65% and slightly, but insignificantly, decreased the potency of lead (-log EC50 = 4.82 ± 0.1). The inactive phorbol ester, phorbol 12-myristate 13-acetate 4-0-methyl ether (1 × 10-6 M), did not alter contractile responses to lead (-log EC50 = 4.92 ± 0.09). Vascular contraction to lead partially depends on extracellular calcium as the L-type voltage-gated calcium channel antagonist, verapamil (3 × 10-6 M), decreased leadinduced contractions by 50%. These data indicate that lead interacts with PKC in an endothelium-independent, calcium-dependent manner to cause vascular smooth muscle contraction and suggest that lead-induced increases in vascular contractility may play a role in lead-induced hypertension.

AB - Animal studies have demonstrated that low-level lead exposure produces hypertension and that lead can cause contraction of vascular smooth muscle directly. The physiological effects of lead have been associated with both stimulation and inhibition of protein kinase C (PKC). Given that vascular smooth muscle contractility is generally enhanced when protein kinase C is activated, we have tested the hypothesis that lead contracts vascular smooth muscle via stimulation of PKC. Helically-cut strips of rabbit mesenteric artery were mounted in muscle baths for measurement of isometric force development. Cumulative addition of lead acetate (10-10-10-3 M) to the muscle bath produced contractions (concentration necessary to produce half-maximal response -log EC50 = 5.16 ± 0.07). Maximal contraction to lead acetate in arteries denuded of endothelium did not differ from those in intact vessels, supporting the hypothesis that lead-induced contraction is an endothelium-independent event. Contractions to lead acetate were potentiated by the PKC activators, phorbol 12-myristate 13-acetate (TPA; 3 × 10-7 M) and mezerein (3 × 10-7 M), as indicated by leftward shifts in the concentration-response curve and increase in the potency of lead (-log EC50 with TPA: 6.94 ± 0.07; -log EC50 with mezerein: 6.07 ± 0.04). H-7 (6 × 10-6 M), an inhibitor of PKC, decreased maximal contraction to lead ~65% and slightly, but insignificantly, decreased the potency of lead (-log EC50 = 4.82 ± 0.1). The inactive phorbol ester, phorbol 12-myristate 13-acetate 4-0-methyl ether (1 × 10-6 M), did not alter contractile responses to lead (-log EC50 = 4.92 ± 0.09). Vascular contraction to lead partially depends on extracellular calcium as the L-type voltage-gated calcium channel antagonist, verapamil (3 × 10-6 M), decreased leadinduced contractions by 50%. These data indicate that lead interacts with PKC in an endothelium-independent, calcium-dependent manner to cause vascular smooth muscle contraction and suggest that lead-induced increases in vascular contractility may play a role in lead-induced hypertension.

KW - Calcium

KW - Endothelium

KW - Environmental lead

KW - Phorbol esters

KW - Protein kinase C

KW - Vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=0029007474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029007474&partnerID=8YFLogxK

U2 - 10.1016/0300-483X(94)03003-K

DO - 10.1016/0300-483X(94)03003-K

M3 - Article

VL - 99

SP - 55

EP - 65

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 1-2

ER -